Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery (IMAGE)

InSilico Medicine

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Caption

Under the agreement, Insilico will lead AI-driven discovery to identify molecules meeting predefined scientific and early development criteria, while Takeda will apply its global development capabilities to advance selected candidates through clinical validation.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.